Skip to content
Adjuvance Technologies
Empowering health.
About Us
Our Technology
Our Leadership
Board of Directors
Management Team
Investors & Media
Contact
JACS: Design and synthesis of potent Quillaja saponin vaccine adjuvants.
By
jgardner
February 17, 2010
Publications
Jacs_design_nihms172184
Jacs_design_nihms172184
Post navigation
Preclinical Evaluation of the Synthetic Adjuvant SQS-21 and its Constituent Isomeric Saponins